The 'mind-blow­ing' R&D re­nais­sance in psy­che­del­ic meds finds a home at Johns Hop­kins

The “mind-blow­ing” field of psy­che­del­ic re­search is get­ting its first ma­jor US home, one that could help le­git­imize a field that has slow­ly crept out of the shad­ows over the last two decades.

Johns Hop­kins Med­i­cine an­nounced Wednes­day they are open­ing what they be­lieve to be the first cen­ter for psy­che­del­ic re­search in the coun­try and the largest in the world.

The Cen­ter for Psy­che­del­ic and Con­scious­ness Re­search at Johns Hop­kins Med­i­cine will in­clude a team of 11 fac­ul­ty sci­en­tists and post-docs in­ves­ti­gat­ing the po­ten­tial use of LSD and psilo­cy­bin (the chem­i­cal found in mag­ic mush­rooms) — among oth­er psy­che­delics — to im­pact hu­man cre­ativ­i­ty and well-be­ing and to treat a host of dis­or­ders, in­clud­ing opi­oid ad­dic­tion, Alzheimer’s dis­ease and PTSD.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER